GLP-1 Medications Explained: What They Are & How They Work

What Is GLP-1 and Why Does It Matter for Weight Loss?

If you've heard friends mention GLP-1 medications, seen headlines about semaglutide, or wondered whether these treatments could work for you, you're not alone. GLP-1 has become one of the most searched health topics in recent years — and for good reason. These medications represent a significant shift in how clinicians approach medical weight loss, backed by rigorous clinical trials and FDA approval.

GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces in your intestines after eating. Its primary job is to regulate blood sugar and appetite. GLP-1 medications mimic this hormone, amplifying its effects to help you feel fuller longer, reduce cravings, and lose weight in a way that's sustainable when combined with lifestyle changes.

This isn't about willpower or quick fixes. It's about working with your body's biology to create lasting change. Let's break down exactly how these medications work, what the research shows, and what you need to know if you're considering treatment.

How GLP-1 Medications Work in Your Body

When you eat, your intestines release natural GLP-1. This hormone does several important things:

The problem is that natural GLP-1 breaks down within minutes. Your body has an enzyme called DPP-4 that degrades it quickly. GLP-1 medications are engineered to resist this breakdown, extending the hormone's effects from minutes to days or even a full week.

This extended action creates consistent appetite regulation and metabolic support that makes it genuinely easier to eat less without feeling deprived or battling constant hunger.

The Two Main Types of GLP-1 Medications

There are two categories of medications in this space:

Pure GLP-1 receptor agonists like semaglutide (branded as Wegovy for weight loss, Ozempic for diabetes) work exclusively on GLP-1 pathways. Compounded semaglutide programs have made this medication more accessible for adults pursuing medical weight loss through clinician-prescribed treatment.

Dual GIP/GLP-1 receptor agonists like tirzepatide (branded as Zepbound for weight loss, Mounjaro for diabetes) activate both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action may enhance weight loss results for some patients. Many clinicians now offer compounded tirzepatide as part of comprehensive weight management programs.

Both types are administered by injection, typically once weekly. The injection is subcutaneous (under the skin), using a small needle similar to insulin pens. Most patients report minimal discomfort.

What the Clinical Evidence Actually Shows

The weight loss results from major clinical trials have been substantial:

STEP trials (semaglutide): In the STEP 1 trial published in the New England Journal of Medicine, participants lost an average of 14.9% of their body weight over 68 weeks when combining semaglutide 2.4mg with lifestyle intervention, compared to 2.4% with placebo.

SURMOUNT trials (tirzepatide): The SURMOUNT-1 trial showed participants lost up to 22.5% of body weight with the highest dose (15mg) over 72 weeks, combined with reduced-calorie diet and increased physical activity.

These aren't small studies. STEP 1 enrolled 1,961 adults. SURMOUNT-1 enrolled 2,539. The evidence base is robust, peer-reviewed, and has led to FDA approval for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition.

Importantly, these studies also tracked metabolic improvements: reduced blood pressure, improved lipid panels, better glycemic control, and reduced cardiovascular risk markers.

Who Is a Candidate for GLP-1 Treatment?

The FDA has approved GLP-1 medications for weight management in adults who meet specific criteria:

You're not a candidate if you:

A new patient consultation with a licensed clinician will review your full medical history, current medications, and weight loss goals to determine if GLP-1 therapy is appropriate and safe for you.

Not sure if you qualify? Body Good Studio's free 60-second quiz can give you an initial eligibility assessment based on clinical guidelines.

Common Side Effects and How to Manage Them

Like all medications, GLP-1 treatments come with potential side effects. The most common are gastrointestinal:

These side effects typically peak in the first few weeks after starting or increasing your dose, then diminish as your body adjusts. Most patients continue treatment because the benefits outweigh temporary discomfort.

Practical Strategies That Help

If side effects become severe or don't improve, talk to your clinician. Dose adjustments or slower titration schedules often resolve issues.

Cost, Access, and Insurance Coverage

One of the biggest barriers to GLP-1 treatment has been cost. Brand-name medications can exceed $1,000 per month without insurance coverage.

Insurance coverage varies widely. Some plans cover GLP-1 medications for weight loss; others cover them only for diabetes. Medicare Part D currently does not cover weight loss medications, though this may change with pending legislation.

Compounded semaglutide and tirzepatide have emerged as more affordable alternatives. These are prepared by FDA-registered 503B compounding pharmacies using the same active ingredients as brand-name versions, typically at a fraction of the cost.

Body Good Studio offers transparent pricing and works with insurance when possible. You can check your coverage probability using the insurance checker before committing to treatment.

Telehealth has also transformed access. You can now consult with licensed clinicians, receive prescriptions, and have medications shipped discreetly to your door — no waiting rooms, no judgment, no logistical barriers.

What to Expect When Starting Treatment

GLP-1 therapy isn't a passive process. Here's what a typical treatment journey looks like:

Weeks 1-4: You'll start at a low dose to minimize side effects. You may notice reduced appetite and slightly slower digestion. Weight loss in the first month is often modest — 1-4% of body weight.

Weeks 5-12: Your clinician will increase your dose gradually (usually every 4 weeks). Appetite suppression becomes more noticeable. Many patients report significantly reduced food noise and cravings. Weight loss accelerates.

Months 4-12: You'll continue titrating toward your optimal maintenance dose. Weight loss continues, though the rate may slow. This is also when you're building sustainable habits around nutrition and movement.

Ongoing maintenance: Some patients stay on GLP-1 medications long-term to maintain their results. Others taper off once they've established new lifestyle patterns. This decision should be made collaboratively with your clinician based on your individual response and goals.

GLP-1 and Lifestyle: Not Either/Or

These medications are not a replacement for healthy eating and physical activity. They're tools that make those behaviors more achievable.

When you're not battling constant hunger or intrusive food thoughts, it becomes genuinely easier to:

Most effective medical weight loss programs, including those at Body Good Studio, combine GLP-1 medications with nutrition coaching and lifestyle support to help you build skills that last beyond medication use.

Frequently Asked Questions

How long do I need to stay on GLP-1 medications?

There's no universal answer. Some patients use GLP-1 medications for 6-12 months to reach their goal weight, then maintain through lifestyle changes. Others stay on a maintenance dose long-term, similar to how someone might take a statin for cholesterol. The decision depends on your individual response, health goals, side effects, and preferences. Your clinician will help you determine the right duration.

Can I start with a non-injection option?

Yes. Oral GLP-1 medications are now available. Body Good Studio offers an oral GLP-1 starter option for adults who want to try medical weight loss without injections. Oral semaglutide (branded as Rybelsus) is FDA-approved, though it may be slightly less effective than injectable forms for weight loss.

Will I gain the weight back when I stop?

Weight regain is possible if you return to previous eating patterns. That's why combining medication with sustainable behavior changes is critical. The goal is to use the medication window to build new habits, address emotional eating patterns, and create an environment that supports long-term maintenance. Many patients maintain significant weight loss after discontinuing GLP-1 medications when they've made meaningful lifestyle changes.

Are GLP-1 medications safe for long-term use?

Current evidence supports safety for extended use. Semaglutide and tirzepatide have been studied for up to 2+ years in clinical trials with acceptable safety profiles. Long-term cardiovascular outcome trials are ongoing. As with any medication, your clinician will monitor you regularly for adverse effects and adjust treatment as needed.

What if I can't use GLP-1 medications?

There are alternative medical weight loss options. Bupropion combined with naltrexone is an FDA-approved non-GLP-1 medication for chronic weight management. It works through different mechanisms — reducing appetite and affecting reward pathways in the brain. It may be appropriate if you have contraindications to GLP-1 therapy.

Ready to Start Your Weight Loss Journey?

Body Good Studio's clinician-prescribed programs make medical weight loss accessible, affordable, and personalized. Whether you're curious about GLP-1 medications, need insurance guidance, or want to explore all your options, our licensed clinicians will create a treatment plan tailored to your health history and goals.

Take our free 60-second quiz to see if you qualify — most members get a treatment plan in under 24 hours. You'll get transparent pricing, discreet shipping, and ongoing clinical support throughout your journey.

Want to learn more first? Explore our complete library of evidence-based articles at the Body Good Studio blog, where we cover everything from managing side effects to understanding the latest clinical research on GLP-1 medications and sustainable weight loss.